Antibiotic Resistance and Biofilm Formation in Pseudomonas aeruginosa from Different Clinical Samples in Nasiriya, Iraq

Authors

  • Ali Saud Department of Medical Laboratory Technology, College of Health and Medical Technology, Middle Technical University, Iraq.‎
  • Raghad Hassan Hussein Department of Medical Laboratory Technology, College of Health and Medical Technology, Middle Technical University, Iraq.‎
  • Yousor Majid Jameel Medical Technical Institute Al-Mansour, Middle Technical University, Baghdad, Iraq

DOI:

https://doi.org/10.32792/utq/utjsci/v12i1.1342

Keywords:

Pseudomonas aeruginosa, Antibiotic resistance, Biofilm formation

Abstract

Background: Pseudomonas aeruginosa is recognized as the main cause of nosocomial infections. The study aimed to investigate biofilm formation and antibiotic resistance patterns in clinical isolates of P. aeruginosa from various clinical samples from 12 to 70 ages. Methodology: This study included 120 samples obtained from Al-Hussein Teaching Hospital, Al-Nasiriya Teaching Hospital, Al-Haboubi Teaching Hospital, and Mohammed Al-Mousawi Children's Hospital in Nasiriya from January 2023 to June 2023. The samples included 56 wound swabs from cancer patients, 27 burn swabs from burn patients, 18 sputa, 14 ear swabs, and 5 bronchial-aspirate samples. The ages of the patients ranged between 12 and 70 years, and both sexes were represented. The drug susceptibility pattern and biofilm formation were performed for all the isolates. Results: After the final diagnosis, 80 samples (67%) were confirmed to be Pseudomonas aeruginosa. These isolates were obtained from 61 males (76.25%) and 19 females (23.75%).e highest resistance of P. aeruginosa to antibiotics was against the antibiotics Cefepime (96.25%), Amikacin (91.25%), Gentamicin (81.25%), and resistance to Ciprofloxacin was (76.25%), Ceftazidime (66.25%), Piperacillin (48.8%), and Aztreonam (47.5%). On the other hand, the lowest resistance reported in the present study was towards Colistin Sulphate (1.25%), followed by Imipenem (3.75%) and Meropenem (5%). In addition, the results of biofilm formation showed that 57 (71.25%) were non-biofilm producers, 10 (12.5%) were weak biofilm producers, 11 (13.75%) were moderate biofilm producers, and 2 (2.5%) were strong biofilm producers. Conclusion: no correlation was found between antibiotic resistance and biofilm formation.

 

References

‎[1]‎ S. Al-Shimmary, "Molecular identification and ‎prevalence of some virulence genes among ‎Pseudomonas aeruginosa isolated from Iraqi ‎patients," International Journal of ‎Pharmaceutical Research, vol. 1, 2020.‎

‎[2]‎ R. Polse, H. Khalid, and W. Mero, "Molecular ‎Identification and Detection of Virulence Genes ‎Among Pseudomonas Aeruginosa Isolated from ‎Burns Infections," Journal of Contemporary ‎Medical Sciences, vol. 10, 02/26 2024.‎

‎[3]‎ S. Mengal¹, M. Taj, F. Rehman, U. Zafar, A. ‎Mengal, A. Hussain, et al., "Pseudomonas ‎aeruginosa as a pathogenic Organism," ‎International Journal of Biosciences (IJB), vol. ‎‎14, pp. 286-291, 04/15 2019.‎

‎[4]‎ E. Ahmed, "Multidrug Resistant Pseudomonas ‎‎(P) aeruginosa : Medical Impact, Pathogenicity, ‎Resistance Mechanisms and Epidemiology," vol. ‎‎5, 10/23 2017.‎

‎[5]‎ A. Karruli, C. Catalini, C. D'Amore, F. Foglia, F. ‎Mari, A. Harxhi, et al., "Evidence-Based ‎Treatment of Pseudomonas aeruginosa ‎Infections: A Critical Reappraisal," Antibiotics ‎‎(Basel), vol. 12, Feb 16 2023.‎

‎[6]‎ P. Pachori, R. Gothalwal, and P. Gandhi, ‎‎"Emergence of antibiotic resistance ‎Pseudomonas aeruginosa in intensive care unit; ‎a critical review," Genes Dis, vol. 6, pp. 109-‎‎119, Jun 2019.‎

‎[7]‎ L. Y. Chimi, M. Noubom, B. N. Bisso, G. S. ‎Singor Njateng, and J. P. Dzoyem, "Biofilm ‎Formation, Pyocyanin Production, and ‎Antibiotic Resistance Profile of Pseudomonas ‎aeruginosa Isolates from Wounds," International ‎Journal of Microbiology, vol. 2024, p. 1207536, ‎‎2024.‎

‎[8]‎ J. J. Biemer, "Antimicrobial susceptibility testing ‎by the Kirby-Bauer disc diffusion method," Ann ‎Clin Lab Sci (1971), vol. 3, pp. 135-40, Mar-Apr ‎‎1973.‎

‎[9]‎ P. D. Tamma, P. N. A. Harris, A. J. Mathers, E. ‎Wenzler, and R. M. Humphries, "Deconstructing ‎the 2023 Clinical and Laboratory Standards ‎Institute Revised Piperacillin-Tazobactam ‎Breakpoints Against Pseudomonas aeruginosa," ‎Clinical Infectious Diseases, vol. 76, pp. 1868-‎‎1870, 2023.‎

‎[10]‎ M. M. Abdullah and W. M. Mehdi, "Isolation and ‎Identification of Bacteria from The Middle Ear, ‎Nose, Pharynx , Phenotypic and Investigation of ‎Biofilm Formation in Isolated Bacteria," ‎Egyptian Academic Journal of Biological ‎Sciences, G. Microbiology, vol. 14, pp. 231-237, ‎‎2022.‎

‎[11]‎ E. Babapour, A. Haddadi, R. Mirnejad, S.-A. ‎Angaji, and N. Amirmozafari, "Biofilm ‎formation in clinical isolates of nosocomial ‎Acinetobacter baumannii and its relationship ‎with multidrug resistance," Asian Pacific ‎Journal of Tropical Biomedicine, vol. 6, pp. 528-‎‎533, 2016/06/01/ 2016.‎

‎[12]‎ E. A. Edward, M. R. El Shehawy, A. ‎Abouelfetouh, and E. Aboulmagd, "Prevalence ‎of different virulence factors and their ‎association with antimicrobial resistance among ‎Pseudomonas aeruginosa clinical isolates from ‎Egypt," BMC Microbiology, vol. 23, p. 161, ‎‎2023/06/03 2023.‎

‎[13]‎ S. Attiah, H. Ghanim, and D. Khudhur, ‎Molecular Detection of the exoU and toxA genes ‎among Pseudomonas aeruginosa of patients ‎with burn and wound infection in Baghdad City, ‎‎2021.‎

‎[14]‎ A. Kadry, M. Ezz, and H. Abbas, "Phenotypic ‎and genotypic characterization of Pseudomonas ‎aeruginosa siderophores," Zagazig Journal of ‎Pharmaceutical Sciences, vol. 27, pp. 22-30, ‎‎06/01 2018.‎

‎[15]‎ S. M. El-Ageery and A. A. M. Al Otibi, ‎‎"Phenotypic and Genotypic Characterization of ‎Pseudomonas Aeruginosa Isolates from Burn ‎Patients," Egyptian Journal of Medical ‎Microbiology, vol. 25, pp. 53-60, 2016.‎

‎[16]‎ A. J. Kzar and M. M. Sehree, "Study the Wide ‎Variety of Prospective Bacterial Pathogens in ‎Infections of Burns and Wound Patients in ‎Baghdad City," 2024.‎

‎[17]‎ S. Al-Bayati, S. Alahmer, A.-M. Shami, A. Al-‎Azawi, and S. Al-Bayati, "ISOLATION AND ‎IDENTIFICATION OF PSEUDOMONAS ‎AERUGINOSA FROM CLINICAL SAMPLES," ‎Biochemical and Cellular Archives, vol. 21, pp. ‎‎3931-3935, 03/14 2022.‎

‎[18]‎ R. D. Al-Obaidi and H. O. M. Al-Dahmoshi, ‎‎"Biofilm and antibiotic resistance profile among ‎Pseudomonas aeruginosa isolated from clinical ‎samples," Eurasian Journal of Biosciences, vol. ‎‎14, pp. 1135-1139, 2020.‎

‎[19]‎ R. Jawad, "Antibiotic susceptibility patterns of ‎Pseudomonas aeruginosa isolated from clinical ‎and hospital environmental samples in ‎Nasiriyah, Iraq," African journal of ‎microbiology research, vol. 10, pp. 844-849, ‎‎2016.‎

‎[20]‎ M. Dash, S. Padhi, M. V. Narasimham, and S. ‎Pattnaik, "Antimicrobial resistance pattern of ‎Pseudomonas aeruginosa isolated from various ‎clinical samples in a tertiary care hospital, South ‎Odisha, India," Saudi Journal for Health ‎Sciences, vol. 3, pp. 15-19, 2014.‎

‎[21]‎ N. D. Hameed, L. H. Mahdi, and K. H. Rasool, ‎‎"Antibiotic Sensitivity and Biofilm Formation in ‎Pseudomonas aeruginosa Isolated from Wound ‎Infections in Baghdad City," Journal of the ‎College of Basic Education, vol. 30, pp. 43-56, ‎‎2024.‎

‎[22]‎ M. M. Hoque, M. Ahmad, S. Khisa, M. N. Uddin, ‎and R. Jesmine, "Antibiotic resistance pattern in ‎pseudomonas aeruginosa isolated from different ‎clinical specimens," Journal of Armed Forces ‎Medical College, Bangladesh, vol. 11, pp. 45-49, ‎‎2015.‎

‎[23]‎ M. R. S. AL-Rubaye, T. K. Mohammed, and H. N. ‎Abdullah, "Isolation and Diagnosis of Multi ‎Drug Resistance Pseudomonas Aeruginosa from ‎Wound and Burnpatients in Baghdad City," ‎Indian Journal of Forensic Medicine & ‎Toxicology, vol. 14, pp. 2431-2437, 2020.‎

‎[24]‎ S. Ahmed Babani, A. Najati, and K. S. Abass, ‎‎"Isolation and identification of multi-drug ‎resistant "pseudomonas aeruginosa" from burn ‎wound infection in Kirkuk City, Iraq," Eurasian ‎Journal of Medicine, vol. 13, pp. 1045-1050, ‎‎01/01 2019.‎

‎[25]‎ M. K. Al-Khudhairy and M. M. M. Al-Shammari, ‎‎"Prevalence of metallo-β-lactamase-producing ‎Pseudomonas aeruginosa isolated from diabetic ‎foot infections in Iraq," New Microbes New ‎Infect, vol. 35, p. 100661, May 2020.‎

‎[26]‎ P. Karami, P. Mohajeri, R. Yousefi Mashouf, M. ‎Karami, M. H. Yaghoobi, D. Dastan, et al., ‎‎"Molecular characterization of clinical and ‎environmental Pseudomonas aeruginosa isolated ‎in a burn center," Saudi Journal of Biological ‎Sciences, vol. 26, pp. 1731-1736, 2019/11/01/ ‎‎2019.‎

‎[27]‎ S. Golia and M. S. Suhani, "Jyoti. Isolation of ‎Pseudomonas aeruginosa from various Clinical ‎Isolates and it Antimicrobial Resistance Pattern ‎in a Tertiary Care Hospital," Int J CurrMicrobiol ‎App Sci, vol. 5, pp. 247-53, 2016.‎

‎[28]‎ K. Ahmadi, A. M. Hashemian, S. M. ‎Pouryaghobi, R. Akhavan, S. Rozmina, and E. ‎Bolvardi, "Antibiotic resistance properties of ‎Pseudomonas aeruginosa isolated from cases of ‎superficial infections at the emergency unit," ‎Jundishapur journal of microbiology, vol. 9, ‎‎2016.‎

‎[29]‎ G. S. MOAZAMI and F. Eftekhar, "Assessment ‎of carbapenem susceptibility and multidrug-‎resistance in Pseudomonas aeruginosa burn ‎isolates in Tehran," 2013.‎

‎[30]‎ T. Kefale, S. Haile, and K. Desta, "Occurrence of ‎Multiple, Extensive and Pan Drug-Resistant ‎Pseudomonas aeruginosa and Carbapenemase ‎Production from Presumptive Isolates Stored in a ‎Biobank at Ethiopian Public Health Institute," ‎Infection and Drug Resistance, vol. 14, pp. ‎‎3609-3618, 09/04 2021.‎

‎[31]‎ W. Wu, J. Huang, and Z. Xu, "Antibiotic influx ‎and efflux in Pseudomonas aeruginosa: ‎Regulation and therapeutic implications," ‎Microbial Biotechnology, vol. 17, p. e14487, ‎‎2024.‎

‎[32]‎ W. C. Reygaert, "An overview of the ‎antimicrobial resistance mechanisms of ‎bacteria," AIMS Microbiol, vol. 4, pp. 482-501, ‎‎2018.‎

‎[33]‎ M. I. Nader, A. A. Kareem, M. N. Rasheed, and ‎M. A. Issa, "Biofilm formation and detection of ‎pslÁ gene in multidrug resistant Pseudomonas ‎aeruginosa isolated from Thi-Qar, Iraq," Iraqi ‎journal of biotechnology, vol. 16, 2017.‎

‎[34]‎ S. A. Yousef, I. B. Hassan, and M. T. Al-Musawi, ‎‎"DETECTION OF MULTI-DRUG RESISTANT ‎AND BIOFILM FORMATION OF ‎PSEUDOMONAS AERUGINOSA CLINICAL ‎ISOLATES FROM DIYALA HOSPITALS," 2023 ‎‎2023.‎

‎[35]‎ R. A. K. AL-Fridawy, W. A. H. Al-Daraghi, and ‎M. H. Alkhafaji, "Isolation and identification of ‎multidrug resistance among clinical and ‎environmental Pseudomonas aeruginosa ‎isolates," Iraqi journal of biotechnology, vol. ‎‎19, 2020.‎

‎[36]‎ A. Kunwar, P. Shrestha, S. Shrestha, S. Thapa, S. ‎Shrestha, and N. M. Amatya, "Detection of ‎biofilm formation among Pseudomonas ‎aeruginosa isolated from burn patients," Burns ‎Open, vol. 5, pp. 125-129, 2021.‎

‎[37]‎ D. M. P. D. Oliveira, B. M. Forde, T. J. Kidd, P. N. ‎A. Harris, M. A. Schembri, S. A. Beatson, et al., ‎‎"Antimicrobial Resistance in ESKAPE ‎Pathogens," Clinical Microbiology Reviews, vol. ‎‎33, pp. 10.1128/cmr.00181-19, 2020.‎

‎[38]‎ P. Nasirmoghadas, S. Yadegari, S. Moghim, B. N. ‎Esfahani, H. Fazeli, F. Poursina, et al., ‎‎"Evaluation of Biofilm Formation and ‎Frequency of Multidrug-resistant and Extended ‎Drug-resistant Strain in Pseudomonas ‎aeruginosa Isolated from Burn Patients in ‎Isfahan," Advanced Biomedical Research, vol. 7, ‎p. 61, 2018.‎

Downloads

Published

2025-06-27

Issue

Section

Articles

Categories

How to Cite

Saud, A., Raghad Hassan Hussein, & Yousor Majid Jameel. (2025). Antibiotic Resistance and Biofilm Formation in Pseudomonas aeruginosa from Different Clinical Samples in Nasiriya, Iraq. University of Thi-Qar Journal of Science, 12(1), 216-223. https://doi.org/10.32792/utq/utjsci/v12i1.1342